JENNIFER WEAVER: Open Payments
NPI 1679299416 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 54 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 6 | $205 |
| PFIZER INC. | 13 | $189 |
| Amgen Inc. | 5 | $149 |
| Novartis Pharmaceuticals Corporation | 6 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Merck Sharp & Dohme LLC | 5 | $117 |
| Novo Nordisk Inc | 1 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
Products named: FUROSCIX, REPATHA, LEQVIO, Kerendia, ELIQUIS, VYNDAQEL, VERQUVO, Ozempic.
Industry payments across PA — which companies pay providers there.
